// App-Quantinova.ai

BS39 : Targeting BACE1 to improve angiogenesis in type 2 diabetes

Researchers

Presenter

  • Eva Clavane

Principal Investigators

  • N/A

Medical Centers

  • University of Leeds, Light Laboratories University of Leeds Leeds, WYK LS AA United Kingdom, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Type 2 diabetes mellitus

Biomarkers

  • N/A

Drug/Treatment

  • Occlusal-HP Topical

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved